SHPMF (Shanghai Pharmaceuticals Holding Co) Other Long-Term Liabilities: $380 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHPMF Shanghai Pharmaceuticals Holding Co Ltd SHPMF
81 GF Score
Price $1.46
GF Value $1.80
! 4 Warning Signs
View Full Analysis

What is Shanghai Pharmaceuticals Holding Co Other Long-Term Liabilities?

Shanghai Pharmaceuticals Holding Co SHPMF -4.58% 81 Other Long-Term Liabilities is $380 Mil as of Mar. 2026. GuruFocus rates SHPMF with a GF Score™ of 81/100 and a GF Value™ of $1.80. The stock has 4 warning signs investors should review.

Shanghai Pharmaceuticals Holding Co's other long-term liabilities for the quarter that ended in Mar. 2026 was $380 Mil.

Shanghai Pharmaceuticals Holding Co's quarterly other long-term liabilities increased from Sep. 2025 ($386 Mil) to Dec. 2025 ($387 Mil) but then declined from Dec. 2025 ($387 Mil) to Mar. 2026 ($380 Mil).

Shanghai Pharmaceuticals Holding Co's annual other long-term liabilities declined from Dec. 2023 ($265 Mil) to Dec. 2024 ($227 Mil) but then increased from Dec. 2024 ($227 Mil) to Dec. 2025 ($387 Mil).

Shanghai Pharmaceuticals Holding Co Other Long-Term Liabilities Related Terms

Shanghai Pharmaceuticals Holding Co Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Shanghai Pharmaceuticals Holding Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co Other Long-Term Liabilities Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 565.02 262.93 264.88 227.00 386.96

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 224.53 405.80 386.20 386.96 380.04
SHPMF
81GF Score
Shanghai Pharmaceuticals Holding Co Ltd SHPMF
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Pharmaceuticals Holding Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $380 Mil mean?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a Other Long-Term Liabilities of $380 Mil as of Mar. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors.
Is Shanghai Pharmaceuticals Holding Co's Other Long-Term Liabilities too high?
Shanghai Pharmaceuticals Holding Co's current Other Long-Term Liabilities is $380 Mil. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's Other Long-Term Liabilities compare to MCK and COR?
Shanghai Pharmaceuticals Holding Co's Other Long-Term Liabilities of $380 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Medical Distribution company?
A good Other Long-Term Liabilities depends on the Medical Distribution industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. Shanghai Pharmaceuticals Holding Co's current Other Long-Term Liabilities is $380 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a current Other Long-Term Liabilities of $380 Mil. The stock's GF Value™ is $1.80, compared to a current price of $1.46 — trading 18.9% below its estimated fair value. The current Other Long-Term Liabilities is $380 Mil. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (SHPMF), the current Other Long-Term Liabilities is $380 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Pharmaceuticals Holding Co (SHPMF) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of $1.46 is trading 18.9% below its estimated GF Value™ of $1.80.

Key valuation signals for SHPMF:

  • Other Long-Term Liabilities: $380 Mil
  • GF Value™: $1.80 vs. price of $1.46 (18.9% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the SHPMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Pharmaceuticals Holding Co Business Description

Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
81GF Score

Get the complete analysis for SHPMF

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.46
Price
$1.80
GF Value